Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06373003Recruiting

Negative Antiphospholipid Syndrome: a Multicentric Study

Role: lead

NCT05717179Not ApplicableRecruiting

Ultrasound to Guide Treatment Decisions in Patients With Rheumatoid Arthritis According to a T2T Approach

Role: lead

NCT03330769Unknown

Ultrasound in Psoriatic Arthritis Treatment

Role: collaborator

NCT01549210Completed

Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life

Role: lead

All 4 trials loaded